Please login to the form below
Middle East
This page shows the latest Middle East news and features for those working in and with pharma, biotech and healthcare.
Merck signs separate agreements with Seattle Genetics for two cancer drugs
In a separate agreement, Seattle Genetics has granted Merck an exclusive license to commercialise Tukysa (tucatinib), a small molecule tyrosine kinase inhibitor, in Asia, the Middle East, Latin America and other
Latest news
-
Takeda to sell Japan consumer health unit for $2.3bn
This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.
-
New coronavirus sees drug developers scramble to develop a vaccine
viruses such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome ( MERS). ... Last week, the first death of a coronavirus patient outside Hubei was confirmed - the patient died in northern Hebei province and another death was
-
J&J’s new Darzalex formulation OK’d for use in Europe
Every year over 48, 000 people in Europe are diagnosed with multiple myeloma, which is considered to be incurable,” said Patrick Laroche, haematology therapy area lead, Europe, Middle East and Africa
-
Takeda divests over-the-counter and prescription drugs to Stada for $660m
These markets include Near East, Middle East and Africa (NEMEA) countries. ... It said it plans to divest approximately 30 of its pharmaceutical assets to Acino – the Swiss pharma has a clear focus on selected markets in the Middle East, Africa, the
-
Takeda offloads select portfolio to Acino ahead of Shire takeover
These markets comprise Near East, Middle East and Africa (NEMEA) countries, which are all within Takeda’s Growth and Emerging Markets Business Unit. ... Takeda is set to sell approximately 30 of its pharmaceutical assets to the Swiss pharma, which has
More from news
Approximately 1 fully matching, plus 131 partially matching documents found.
Latest Intelligence
-
As COVID-19 takes over the world, biopharma fights back
respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
-
Keeping up the fight against HIV and using the lessons to tackle other threats
their big budget spreadsheets,” said Mike Elliott (pictured above), Vice President of Medical Affairs for Europe, Middle East &Australasia for Gilead Sciences.
-
Leading AstraZeneca’s return to growth in Europe
Care in Central and Eastern Europe, Middle East and Africa before landing the general manager role in Russia in 2014.
-
Bluebird: on a mission to ‘recode’ the DNA of healthcare
Obenshain insisted, however, that Bluebird is investing for a long-term independent future, with its sights also set on taking Zynteglo into the Middle East and Asia, where beta thalassemia patients
-
The handover: Pfizer reshapes itself for a new era
Pfizer has confirmed to PME that other members of Goettler’s team will be based in Asia, as well as in the US, Europe and the Middle East, reflecting the global
More from intelligence
Approximately 0 fully matching, plus 30 partially matching documents found.
Latest appointments
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Umberto La Magna has decided to join Sinclair Pharma, taking up the role of head of Central and Eastern Europe and Middle East and Africa regions. ... Most recently, La Magna held the role of head of central south-east Europe for Baxter International,
-
Pharnext appoints COO
Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.
-
Anish Mehta appointed CEO of new women's health business
Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.
-
Bayer UK and Ireland appoints new CEO
Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global commercial markets to the group.
-
Paolo Carli appointed as head of MEA at Merck
Middle East, Africa and Turkey (MEA) region.
More from appointments
Approximately 0 fully matching, plus 33 partially matching documents found.
Latest from PMHub
-
It’s Teenage Kicks for Lucid Group
s footprint into Asia Pacific, Africa and Middle East region, and the north west of England, coupled with its highly regarded reputation for scientific content, editorial excellence and digital capability, including
-
Hanover Health launches the Mackay Programme
Opportunities to work with colleagues in our Brussels, Dublin and Middle East offices.
-
It’s been altogether more magic for Lucid Group in 2019
This has allowed Lucid to gain new creative and digital capabilities and increase its footprint in the UK, Asia Pacific and Middle East.
-
Lucid Group increases footprint in UK, Asia Pacific and Middle East with the acquisition of HealthCare21
Lucid Group is delighted to announce its latest acquisition, welcoming colleagues from Healthcare consultancy HealthCare21 into its magic kingdom. Over the last twelve years, Lucid Group has become well known and admired as an industry leader in
-
Emerging Markets: Your Essential Guide
This helpful guide includes both general considerations applicable to all emerging markets as well as specific considerations in key countries and regions including Latin America, ASEAN, Middle East &North Africa and
More from PMHub
Approximately 0 fully matching, plus 22 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- FDA approves Roche’s Actemra COVID-19 trial
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
